ClinicalTrials.gov
public full text
Public Domain
Long-term Safety Study of Alogliptin in Participants With Type 2 Diabetes in Japan
The purpose of this study was to evaluate the long-term safety and efficacy of SYR-322, once daily (QD), to an α-glucosidase inhibitor, three times daily (TID), administered for 40 consecutive weeks in participants who completed a phase 2 dose-ranging study.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Long-term Safety Study of Alogliptin Used in Combination With Thiazolidine in Participants With Type 2 Diabetes in Japan#300394
- A Phase I Study of Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes#807819
- Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation#1140586
- Evaluating Bu Yang Huanwu Decoction For Early Diabetic Vascular Disease#846747
- Effect of LIXIsenatide on the Renal System#1124759
Record · ID 888589
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive